ArticleBMC pulmonary medicine2022

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Yuki Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.